<DOC>
	<DOCNO>NCT02063386</DOCNO>
	<brief_summary>To assess absorption , distribution , metabolism excretion single dose 14C label AZD1722 order define rate rout elimination AZD1722 form , metabolite .</brief_summary>
	<brief_title>AZD1722 Open Label , Absorption Distribution Metabolism Excretion Study</brief_title>
	<detailed_description />
	<criteria>Healthy male volunteer age ≥50 year Regular daily bowel movement . Have body mass index ( BMI ) 18 32 kg/m2 ( inclusive ) weigh least 50 kg 110 kg . History clinically significant disease disorder , opinion Principal Investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate study . History presence GI , hepatic renal disease include GI surgery appendectomy condition know interfere ADME drug . Loose stool ( Bristol Stool Form Score 6 7 ) ≥2 day past 7 day admission study centre Use medication know affect stool consistency and/or GI motility , include fibre supplement , antidiarrheal , prokinetic drug , enema , probiotic medication supplement ; salt electrolyte supplement contain sodium , potassium , chloride , bicarbonate formulation past 7 day admission study centre . Volunteers expose radiation level background ( eg , via Xray examination ) &gt; 5 mSv last year , &gt; 10 mSv last 5 year cumulative total &gt; 1 mSv per year life . Participation previously radiolabelled study within last 5 year</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>